BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
出版年份 2012 全文链接
标题
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
作者
关键词
-
出版物
BLOOD
Volume 120, Issue 14, Pages 2843-2852
出版商
American Society of Hematology
发表日期
2012-08-18
DOI
10.1182/blood-2012-02-413021
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
- (2012) I.-M. Chen et al. BLOOD
- Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
- (2012) Oliver Weigert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
- (2012) Michael J. Kluk et al. PLoS One
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Ribosome biogenesis factors bind a nuclear envelope SUN domain protein to cluster yeast telomeres
- (2011) Chihiro Horigome et al. EMBO JOURNAL
- Gain-of-function mutations ininterleukin-7 receptor-α(IL7R) in childhood acute lymphoblastic leukemias
- (2011) Chen Shochat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
- (2011) S. Rahman et al. MOLECULAR AND CELLULAR BIOLOGY
- A Novel Transcription Complex That Selectively Modulates Apoptosis of Breast Cancer Cells through Regulation of FASTKD2
- (2011) K. T. Yeung et al. MOLECULAR AND CELLULAR BIOLOGY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
- (2011) Priscila P Zenatti et al. NATURE GENETICS
- Improving outcomes for high-risk ALL: Translating new discoveries into clinical care
- (2011) Stephen P. Hunger et al. PEDIATRIC BLOOD & CANCER
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
- (2011) J. M. Lamonica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
- (2010) G. Cario et al. BLOOD
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
- (2010) R. C. Harvey et al. BLOOD
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
- (2010) R. C. Harvey et al. BLOOD
- Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial
- (2010) H. M. Ensor et al. BLOOD
- Absence of G-CSF receptors and absent response to G-CSF in childhood Burkitt's lymphoma and B-ALL cells
- (2010) Jörg Tomeczkowski et al. BRITISH JOURNAL OF HAEMATOLOGY
- Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
- (2010) F. Baffert et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells
- (2009) Junko Okabe-Kado et al. CANCER SCIENCE
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
- (2009) Charles G Mullighan et al. NATURE GENETICS
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
- (2009) A. Yoda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myc's broad reach
- (2008) M. Eilers et al. GENES & DEVELOPMENT
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started